Bachta Artur, Tłustochowicz Mateusz
Z Kliniki Reumatologii Wojskowego Instytutu Medycznego w Warszawie.
Klin Oczna. 2005;107(10-12):710-4.
Autoimmune uveitis is an acute, recurrent, sight-threatening disease that can lead to severe visual loss and blindness. It requires systemic immunosuppressive therapy and continuous monitoring by ophthalmologist and rheumatologist. There are no universally accepted referral patterns for the treatment of endogenous uveitis. Most specialists indicate corticosteroids, methotrexate and cyclosporine A as the first use drugs. Anti-cytokine drugs are a new opportunity for the patients unresponsive to the conventional anti-inflammatory and immunosuppressive therapy.
自身免疫性葡萄膜炎是一种急性、复发性、威胁视力的疾病，可导致严重视力丧失和失明。它需要全身免疫抑制治疗，并由眼科医生和风湿病学家进行持续监测。对于内源性葡萄膜炎的治疗，目前尚无普遍接受的转诊模式。大多数专家指出，皮质类固醇、甲氨蝶呤和环孢素A为首选药物。抗细胞因子药物为对传统抗炎和免疫抑制治疗无反应的患者提供了新的治疗选择。
